期刊文献+

Laparoscopic liver resection in the cirrhotic patient

原文传递
导出
摘要 Aim:The adoption of laparoscopic liver resection has been expansive in the last 2 decades with the exception of cirrhotic patients.The current study examines the outcomes of our cirrhotic resections to determine the potential limitations of this technique.Methods:Retrospective analysis of 114 cirrhotic patients.Seventy-five(65.8%)laparoscopic resections were compared to 39 open resections.Seventy-six(66.7%)resections in the series were minor resections(less than 3 segments).Surgical approach and extent of resection were analyzed using student’s t test and regression multivariate analysis with SAS.Results:The laparoscopic group had lower operative times(2.4 vs.4.8 h;P<0.001),blood loss(250 vs.609 mL;P<0.001),length of stay(4.4 vs.10.1 days;P=0.013)a nd c omplications(28%vs.48%;P=0.028).Subset analysis by technique and extent of resection identified the laparoscopic group lost the advantage in blood loss and lengths of stay when utilized in major resections.Multivariate regression analysis for blood loss further confirmed open resection(P=0.014)a nd major resection(P=0.026)a s significant i ndicators of bleeding and transfusion.Conclusion:Laparoscopic liver resection in cirrhotic patients is safe and efficacious.However,the significant variability in outcomes for major resections in cirrhotics leads us to recommend further examination of the learning curve and significant caution in the selection of cirrhotics requiring major hepatic resections.
出处 《Hepatoma Research》 2016年第1期248-252,共5页 肝癌研究(英文版)
  • 相关文献

参考文献3

二级参考文献164

  • 1Sheng, Qin-Song,Lang, Ren,He, Qiang,Yang, Yong-Jiu,Zhao, De-Fang,Chen, Da-Zhi.Indocyanine green clearance test and model for end-stage liver disease score of patients with liver cirrhosis[J].Hepatobiliary & Pancreatic Diseases International,2009,8(1):46-49. 被引量:37
  • 2Virginia Hernandez-Gea,Fanny Turon,Annalisa Berzigotti,Augusto Villanueva.Management of small hepatocellular carcinoma in cirrhosis:Focus on portal hypertension[J].World Journal of Gastroenterology,2013,19(8):1193-1199. 被引量:20
  • 3■ukasz Liszka,Ewa Zielińska-Paj■k,Jacek Paj■k,Dariusz Goka,Jacek Starzewski,Zbigniew Lorenc.Usefulness of two independent hist classifications of tumor regression iUsefulness of two independent histopathological classifications of tumor regression in patients with rectal cancer submitted to hyperfractionated pre-operative radiotherapy[J].World Journal of Gastroenterology,2007,13(4):515-524. 被引量:3
  • 4LucaAldrighetti,EleonoraGuzzetti,CarloPulitanò,FedericaCipriani,MarcoCatena,MichelePaganelli,GianfrancoFerla.Case‐matched analysis of totally laparoscopic versus open liver resection for HCC: Short and middle term results[J]. J. Surg. Oncol. . 2010 (1)
  • 5Christopher P. Day,Oliver F.W. James.Steatohepatitis: A tale of two “hits”?[J]. Gastroenterology . 1998 (4)
  • 6Patrick S. Kamath,Russell H. Wiesner,Michael Malinchoc,Walter Kremers,Terry M. Therneau,Catherine L. Kosberg,Gennaro D’Amico,E.Rolland Dickson,W.Ray Kim.A model to predict survival in patients with end-stage liver disease[J]. Hepatology . 2001 (2)
  • 7Mathieu Laplante,David M. Sabatini.mTOR Signaling in Growth Control and Disease[J]. Cell . 2012 (2)
  • 8Chi-Leung Liu,Sheung-Tat Fan,Chung-Mau Lo,Yik Wong,Irene Oi-Lin Ng,Chi-Ming Lam,Ronnie Tung-Ping Poon,John Wong.Abdominal Drainage After Hepatic Resection Is Contraindicated in Patients With Chronic Liver Diseases[J]. Annals of Surgery . 2004 (2)
  • 9Roberto de Franchis.Revising consensus in portal hypertension: Report of the Baveno V consensus workshop on methodology of diagnosis and therapy in portal hypertension[J].Journal of Hepatology.2010(4)
  • 10Ann-Lii Cheng,Yoon-Koo Kang,Zhendong Chen,Chao-Jung Tsao,Shukui Qin,Jun Suk Kim,Rongcheng Luo,Jifeng Feng,Shenglong Ye,Tsai-Sheng Yang,Jianming Xu,Yan Sun,Houjie Liang,Jiwei Liu,Jiejun Wang,Won Young Tak,Hongming Pan,Karin Burock,Jessie Zou,Dimitris Voliotis,Zhongzhen Guan.Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial[J].Lancet Oncology.2009(1)

共引文献46

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部